Business Context and Reporting Period
Company: AEye, Inc. (Ticker: LIDR)
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2025
Reporting Period: Specific event date of July 25, 2025.
Context: The Company is an emerging growth company incorporated in Delaware. This filing reports a corporate action regarding an At Market Issuance Sales Agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a capital market transaction update.
Material Changes
- Amendment to Sales Agreement: On July 25, 2025, the Company filed Amendment No. 3 to its Prospectus Supplements.
- Updated Offering Capacity: The maximum aggregate offering price of Placement Shares issuable under the At Market Issuance Sales Agreement with A.G.P./Alliance Global Partners was updated to $23,728,000.
- Registration Basis: The issuance is pursuant to the Company's effective Form S-3 registration statement (File No. 333-274546), originally filed in September 2023 and previously amended in September 2024, December 2024, and January 2025.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, outlook, or management discussion regarding operational performance. It strictly details the administrative update to the equity offering capacity.
Risks and Contingencies: The filing includes a standard disclaimer stating that the report does not constitute an offer to sell or a solicitation of an offer to buy shares in any jurisdiction where such an offer would be unlawful prior to registration or qualification.
Investor Verification Checklist
- Verify the current market price of AEye common stock (LIDR) to assess potential dilution impact from the $23,728,000 offering capacity.
- Review the original Sales Agreement dated September 12, 2024, to understand the terms and commission structure with A.G.P./Alliance Global Partners.
- Check subsequent filings to determine if and when shares are actually issued under this amended capacity.
- Confirm the Company's current cash position in the most recent 10-Q or 10-K to understand the necessity of this capital raise.